Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-28 4:07 pm Unchanged | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 4,610,257 46.7% | 0 (Unchanged) | View |
| 2024-01-22 4:26 pm Purchase | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 4,610,257 50.9% | 230,532 (+5.26%) | View |
| 2023-12-08 5:28 pm Sale | 13D | EYEPOINT PHARMACEUTICALS, INC. EYPT | EW Healthcare Partners L.P. | 2,337,786 5% | -1,312,606 (-35.96%) | View |
| 2023-10-23 4:05 pm Purchase | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 4,379,725 44.2% | 561,799 (+14.71%) | View |
| 2023-09-14 6:36 pm Sale | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 3,817,926 44.2% | -677,879 (-15.08%) | View |
| 2023-08-30 5:22 pm Sale | 13D | EYEPOINT PHARMACEUTICALS, INC. EYPT | EW Healthcare Partners L.P. | 3,650,392 10.4% | -38,253,564 (-91.29%) | View |
| 2023-07-14 3:23 pm Purchase | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 4,495,805 50.7% | 1,333,975 (+42.19%) | View |
| 2023-05-24 1:22 pm Sale | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 3,161,830 42% | -33,020,126 (-91.26%) | View |
| 2022-11-29 6:04 pm Unchanged | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 36,181,956 40.6% | 0 (Unchanged) | View |
| 2022-11-28 5:17 pm Purchase | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 36,181,956 41.38% | 15,012,499 (+70.92%) | View |
| 2022-02-03 4:09 pm Purchase | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 21,169,457 35.88% | 3,935,626 (+22.84%) | View |
| 2021-02-12 4:36 pm Purchase | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 17,233,831 29.52% | 4,056,856 (+30.79%) | View |
| 2021-02-09 2:21 pm Sale | 13G | AXOGEN, INC. AXGN | EW Healthcare Partners L.P. | 1,981,888 4.94% | -448,111 (-18.44%) | View |
| 2020-03-30 5:51 pm Purchase | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 13,176,975 33.31% | 6,150,114 (+87.52%) | View |
| 2020-02-14 4:26 pm Sale | 13G | AXOGEN, INC. AXGN | EW Healthcare Partners L.P. | 2,429,999 6.16% | -309,752 (-11.31%) | View |
| 2019-11-18 2:19 pm Purchase | 13D | VENUS CONCEPT INC VERO | EW Healthcare Partners L.P. | 7,026,861 23.68% | 7,026,861 (New Position) | View |